Common Childhood Virus Triggered Life-Threatening Lung Failure in Adult Patient

Parvovirus B19 is best known to most people, if it is known at all, as the cause of fifth disease, the mild childhood illness marked by the distinctive ‘slapped cheek’ rash. In healthy adults the virus typically produces little more than a self-limiting fever, joint aches or a transient rash, and it is rarely considered a serious respiratory threat. A new case report published in Respirology Case Reports, however, documents a striking exception to that benign reputation: a 70-year-old Japanese man with pre-existing interstitial lung disease who developed acute, life-threatening respiratory deterioration after a primary parvovirus B19 infection, an outcome so unusual in adults that it prompted the treating physicians to publish the case for the wider pulmonary community.

The patient arrived at the hospital with a low-grade fever and a facial rash, one week after close contact with his daughter, who had been suffering from upper respiratory symptoms. Two years earlier he had been diagnosed with interstitial lung disease, suspected to be bird-related chronic hypersensitivity pneumonitis, a form of inflammatory lung injury driven by exposure to avian antigens such as those from feather duvets and down jackets. His condition had been managed with systemic corticosteroids, which had been carefully tapered and discontinued several months before admission, and he had been rigorously counseled to avoid avian exposures. A former smoker with a 38 pack-year history, he initially received oral levofloxacin from his local physician without improvement, prompting referral to the authors’ hospital.

On admission the clinical picture was deceptively subtle. He was alert, his temperature was 37.0 degrees Celsius, and his oxygen saturation sat at 90 percent on room air while fine crackles could be heard bilaterally and a mild facial rash was visible. Laboratory evaluation showed only mild inflammation, with a C-reactive protein level of 0.89 mg/dL, and importantly, serum KL-6 and surfactant protein D, biomarkers commonly used to track interstitial lung disease activity, remained unchanged from his baseline values. An extensive infectious workup was entirely negative, including serum beta-D-glucan, cytomegalovirus antigenemia, Aspergillus IgG and a multiplex polymerase chain reaction panel for common respiratory pathogens. Given the recent sick contact in the family and the facial rash, clinicians performed parvovirus B19 serology, which returned positive IgM and IgG antibodies, indicating a recent primary infection.

Imaging told a more alarming story. Chest radiography revealed decreased radiolucency in the bilateral middle and lower lung fields compared with films obtained only three months earlier, and high-resolution computed tomography demonstrated newly developed bilateral ground-glass opacities, a finding that in a patient with underlying fibrotic lung disease immediately raises concern for an acute exacerbation. Broad-spectrum antibiotics were started on the assumption of bacterial pneumonia, yet the opacities continued to progress, forcing the team to look deeper. Bronchoscopy was performed, and bronchoalveolar lavage fluid collected from the left B5 segment yielded a total cell count of 1.42 x 10^5 cells per milliliter with striking lymphocytic predominance of 63.5 percent, along with histiocytes at 33.8 percent, neutrophils at 1.0 percent and eosinophils at 1.7 percent.

The decisive result came from molecular testing of that lavage fluid: polymerase chain reaction was positive for parvovirus B19 DNA, directly demonstrating the virus within the lower respiratory tract during the acute phase of illness. Testing for Pneumocystis jirovecii was negative, no pathogenic organisms were isolated in culture, and cytology excluded malignancy. With a compatible exposure history, serologic confirmation of acute infection and viral DNA recovered from the lung itself, the clinicians concluded that the acute respiratory deterioration was associated with parvovirus B19, a diagnosis essentially never made in immunocompetent adults. During hospitalization the serum KL-6 and SP-D levels rose and the patient’s oxygen requirement climbed transiently to 3 liters per minute, reflecting genuine physiologic worsening rather than an incidental imaging finding.

Treatment took the form of high-dose pulsed corticosteroids, with methylprednisolone at 1000 mg per day, which produced rapid clinical and radiological improvement. The patient was transitioned to tapering oral prednisolone and discharged on Day 19 of his admission. At four-month follow-up he remained clinically stable, with sustained resolution of the opacities on serial chest radiographs. The favorable response is notable, though as the authors caution, it does not by itself settle the underlying mechanism, since the suspected bird-related hypersensitivity pneumonitis is generally considered more steroid-responsive than progressive fibrotic diseases such as idiopathic pulmonary fibrosis.

The diagnostic reasoning in this case illuminates a genuine clinical dilemma. Acute exacerbation of interstitial lung disease is defined by rapid respiratory deterioration within one month and the appearance of new bilateral ground-glass opacities on high-resolution computed tomography, criteria that this patient met. Yet distinguishing primary viral pneumonia from infection-triggered acute exacerbation remains notoriously difficult because the two entities overlap substantially in their clinical and radiological features. Previous prospective work cited by the authors detected respiratory viral infections in 19.2 percent of acute exacerbation cases, and such infections are associated with poor short-term outcomes. In this instance, common culprits such as influenza virus and the herpesviruses were excluded, and the absence of any alternative infectious agent or cardiac failure strengthened the case for parvovirus B19 as the causative trigger, although the authors acknowledge that unrecognized avian antigen exposure and progression of the underlying hypersensitivity pneumonitis could not be completely excluded, particularly given the lymphocytic, rather than neutrophilic, lavage profile.

The mechanistic plausibility of parvovirus B19 lung injury rests on well-characterized virology. The virus is a small, non-enveloped, single-stranded DNA virus that enters cells by binding the P antigen, a globoside receptor expressed not only on erythroid progenitors but also on pulmonary endothelial cells. Viral interaction with this receptor may cause endothelial injury, increased vascular permeability and diffuse alveolar damage, the histological substrate of acute lung injury. Experimental studies add a pro-fibrotic dimension: the viral non-structural protein NS1 has been shown to exacerbate fibrotic processes through activation of the TGF-beta/Smad signaling pathway, while the VP1-unique region of the capsid induces inflammatory cytokine release and disrupts epithelial barriers. In a lung already scarred by chronic interstitial disease, these processes could act as a ‘second hit’ that tips a compensated patient into acute exacerbation, providing a coherent biological explanation for what the radiographs and lavage findings captured.

The authors, Tomoki Kishaba and Satoshi Marumo of the Department of Respirology at Kitano Hospital, conclude that although the relative contributions of direct viral lung injury, infection-triggered exacerbation and progression of the underlying bird-related hypersensitivity pneumonitis could not be definitively disentangled, the case highlights the importance of considering parvovirus B19 as a potential contributor to acute respiratory deterioration, particularly in patients with underlying interstitial lung disease. For clinicians, the practical lessons are concrete: a facial rash or known ‘slapped cheek’ contact in an deteriorating ILD patient should prompt parvovirus B19 serology, and bronchoalveolar lavage with viral PCR can identify pathogens that routine respiratory panels miss, since parvovirus B19 does not appear on standard multiplex panels. For virologists and pulmonologists alike, the report underscores how much remains unknown about a virus that infects roughly half of humanity by adulthood, and the authors call for further studies to clarify the mechanisms underlying parvovirus B19-associated pulmonary involvement before such life-threatening presentations are encountered again.

Subject of Research: Acute respiratory deterioration associated with parvovirus B19 infection in a patient with interstitial lung disease.

Article Title: Acute Respiratory Deterioration Following Parvovirus B19 Infection in a Patient With Interstitial Lung Disease: A Case Report

Article References: Kishaba, T., Marumo, S., Nishida, Y., Nohara, E., Higashi, J., Aoki, S., Okura, C., Jinno, S., Tashima, N., Morimoto, C., Kitajima, T., & Inoue, D. (2026). Acute Respiratory Deterioration Following Parvovirus B19 Infection in a Patient With Interstitial Lung Disease: A Case Report. Respirology Case Reports, 14(9), Article e70751. https://doi.org/10.1002/rcr2.70751

Image Credits: AI Generated

DOI: 10.1002/rcr2.70751

Keywords: parvovirus B19, interstitial lung disease, acute exacerbation, hypersensitivity pneumonitis, viral pneumonia, bronchoalveolar lavage, ground-glass opacities, corticosteroids, respiratory infection, lung fibrosis, Acute, Respiratory